Mérieux Equity Partners
Overview
Mérieux Equity Partners is a European investment firm specializing in venture, growth, and buyout investments in the healthcare and nutrition sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Swixx BioPharma | Dec 2025 | Buyout/LBO | Co-investor |
| serb | Feb 2021 | Private Equity | Co-investor |
| HighLife Medical | Sep 2026 | Early Funding | - |
| AstriVax | Aug 2022 | Seed | Co-investor |
| CorFlow Therapeutics AG | Sep 2024 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Jean-François Billet
Managing Partner - Head of Buy-Out
Thierry CHIGNON
Managing Partner
Valérie Calenda
Managing Partner
Jean-Guillaume Lafay
Operating Partner
Cedric Glume
Regional Partner
Jaana Grüter
Partner
Jean Chatillon
Director Of Investor Relations And Communication
Louis Bonnamour
Investor Relations apprentice
Pierre A. Morgon
Regional Partner - Senior Advisor
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Mérieux Equity Partners based?
Mérieux Equity Partners is headquartered in Lyon, France.
When was Mérieux Equity Partners founded?
Mérieux Equity Partners was founded in 2009.
How many portfolio companies does Mérieux Equity Partners have?
Mérieux Equity Partners has 33 portfolio companies in Caplight's dataset.
What are some companies in Mérieux Equity Partners's portfolio?
Portfolio companies visible on Caplight include Swixx BioPharma, serb, HighLife Medical, AstriVax, CorFlow Therapeutics AG.
What was Mérieux Equity Partners's most recent investment shown here?
Mérieux Equity Partners's most recent investment in this portfolio sample was in HighLife Medical in 2026.
What sectors does Mérieux Equity Partners focus on?
Mérieux Equity Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Enterprise Software, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Mérieux Equity Partners focus on?
Mérieux Equity Partners typically invests at the MultiStage stage.
What is Mérieux Equity Partners's AUM?
Mérieux Equity Partners's assets under management are estimated between $1.6B and $1.7B.